Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
about
Multiple D2 heteroreceptor complexes: new targets for treatment of schizophreniaProteostasis and RNA Binding Proteins in Synaptic Plasticity and in the Pathogenesis of Neuropsychiatric DisordersIn Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersThe SocioBox: A Novel Paradigm to Assess Complex Social Recognition in Male Mice.From "directed differentiation" to "neuronal induction": modeling neuropsychiatric diseaseUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismIncreased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia.Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disorders.MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular ActionsGenetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.The promises and challenges of human brain organoids as models of neuropsychiatric disease.Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.Dysregulations of Synaptic Vesicle Trafficking in SchizophreniaNMDA receptor subunit composition controls dendritogenesis of hippocampal neurons through CAMKII, CREB-P, and H3K27ac.Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia.The Effects of Hallucinogens on Gene Expression.Retrogradely Transported TrkA Endosomes Signal Locally within Dendrites to Maintain Sympathetic Neuron SynapsesIntegrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infants.Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice.Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes.D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice.GRIN3B missense mutation as an inherited risk factor for schizophrenia: whole-exome sequencing in a family with a familiar history of psychotic disorders.Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.The tetrapartite synapse: a key concept in the pathophysiology of schizophrenia.Biofunctionalized 3D Nanopillar Arrays Fostering Cell Guidance and Promoting Synapse Stability and Neuronal Activity in Networks.Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
P2860
Q26747736-05002B37-65D7-410B-873B-BAA63D160017Q26767347-99F0E209-00E7-4310-B40B-C707A0BBF299Q26769948-D7CE0B4E-16F4-4CDF-B1E1-603E3A8D8E29Q27320742-648A3084-F8FA-4234-9F12-45C426B223E8Q27692698-09341965-8D54-497A-81DC-79322010F0F9Q28084069-7B467DEE-1085-468E-BAA8-C537BC0F682FQ34665023-E89E6893-2547-47FB-B9A8-F35883924F54Q35883056-F667E95A-8341-44FA-938A-02CD5B890E61Q37094982-5B8E038C-23A5-41B1-AAB0-7B3E01E9889CQ37648269-F9D18432-AE24-4C1F-B2C1-7ABC2AB1B6D7Q38267957-B36D8FDD-A0B8-43CC-9DB4-85D5CE489683Q38770806-8662F317-003B-4463-8911-C154ABD3A6E8Q38783824-818D142B-4BAE-4240-BFDB-4D0082AAE65AQ38802467-7246D27A-08E8-4CE1-AEC8-716708A62FBDQ38851123-0CA4EDC5-0878-4861-AB6A-25F72F1C5851Q38883878-B381B7D8-2F3F-420C-BF54-9FD6ADE863F7Q38979545-7CBC5862-277C-41E3-BD90-F72F82AECB65Q38996513-4BB3E07E-E64B-486D-BDBC-329EBA2AFE77Q39414457-9B74BECF-091F-4BB4-939C-5A2987E1FCDAQ41460503-B938E3AD-C922-404B-9FDB-55B9B7020B2CQ41620055-80A860C8-8AA6-40D2-BD6C-579CE82CAC63Q45874743-DDC38714-91F9-443E-B110-F98281A69EDFQ47871481-20C5F840-1351-43DF-9F36-7BD8A877B7CFQ48057133-7AD38A49-BE4A-4918-88A0-3E299121D26BQ48334514-430C3D6B-0D9F-44B8-AEE3-4ABC346952C4Q50707979-01926A8B-4D1D-417A-81D2-6B225693015DQ52367971-14D5097C-2A6C-443D-9900-4655D3099F60Q55312722-4D9CDDC5-5B3D-4FC1-8FA9-69CB9A121E9FQ55453560-B3165021-B72F-41A3-B12A-AB80D2A86025Q58766074-A1AB46D2-5E90-48BA-A0E6-DE87C54010F6
P2860
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glutamatergic postsynaptic den ...... novel therapeutic approaches.
@en
type
label
Glutamatergic postsynaptic den ...... novel therapeutic approaches.
@en
prefLabel
Glutamatergic postsynaptic den ...... novel therapeutic approaches.
@en
P2093
P2860
P1476
Glutamatergic postsynaptic den ...... r novel therapeutic approaches
@en
P2093
Carmine Tomasetti
Felice Iasevoli
Gianmarco Latte
P2860
P2888
P304
P356
10.1007/S12035-013-8534-3
P577
2013-09-03T00:00:00Z
P5875
P6179
1027529310